MedPath

Evaluation of the effects of quercetin ointment in the prevention of radiation-induced acute proctitis in prostate cancer patients

Phase 3
Recruiting
Conditions
Radiation proctitis.
Radiation proctitis
K62.7
Registration Number
IRCT20120707010205N10
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
50
Inclusion Criteria

prostate cancer patients undergoing radiotherapy with a field encompassing almost whole rectum and receive a minimum dose of 4000 cGy radiation

Exclusion Criteria

Patients with history of previous radiotherapy of pelvis region
Patients receiving treatment with anti-inflammatory drugs (NSAIDS, corticosteroids)
Patients with inflammatory bowel disease (ulcerative colitis , Crohn's disease )

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score of acute proctitis according to the staging system of the Radiation Oncology Group (RTOG). Timepoint: At the beginning of the study and then every week after the start of quercetin ointment consumption. Method of measurement: RTOG criteria to evaluate acute proctitis reaction induced by radiation therapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath